Mark Tomishima

10.0k total citations · 3 hit papers
44 papers, 7.0k citations indexed

About

Mark Tomishima is a scholar working on Molecular Biology, Genetics and Cellular and Molecular Neuroscience. According to data from OpenAlex, Mark Tomishima has authored 44 papers receiving a total of 7.0k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 10 papers in Genetics and 8 papers in Cellular and Molecular Neuroscience. Recurrent topics in Mark Tomishima's work include Pluripotent Stem Cells Research (27 papers), CRISPR and Genetic Engineering (21 papers) and 3D Printing in Biomedical Research (6 papers). Mark Tomishima is often cited by papers focused on Pluripotent Stem Cells Research (27 papers), CRISPR and Genetic Engineering (21 papers) and 3D Printing in Biomedical Research (6 papers). Mark Tomishima collaborates with scholars based in United States, France and Switzerland. Mark Tomishima's co-authors include Lorenz Studer, Stuart M. Chambers, Michel Sadelain, Eirini P. Papapetrou, Christopher A. Fasano, Gabsang Lee, Lynn W. Enquist, Viviane Tabar, Yosif Ganat and Yvonne Mica and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Mark Tomishima

44 papers receiving 6.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling

2009 2.6k citations Stuart M. Chambers, Christopher A. Fasano et al. Nature Biotechnology profile →
Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs

2009 649 citations Gabsang Lee, Eirini P. Papapetrou et al. Nature profile →
Human iPSC-Based Modeling of Late-Onset Disease via Progerin-Induced Aging

2013 549 citations Yosif Ganat, Becky Liu et al. Cell stem cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Tomishima United States	29	5.4k	1.6k	1.1k	1.0k	726	44	7.0k
Stuart M. Chambers United States	24	5.0k 0.9×	1.2k 0.8×	894 0.8×	859 0.8×	532 0.7×	29	6.8k
Jun Takahashi Japan	38	6.1k 1.1×	2.5k 1.6×	1.4k 1.3×	1.7k 1.6×	475 0.7×	112	8.2k
Gabsang Lee United States	29	3.9k 0.7×	1.2k 0.8×	780 0.7×	466 0.5×	500 0.7×	68	5.7k
Frederick J. Livesey United Kingdom	42	6.2k 1.1×	2.0k 1.3×	761 0.7×	1.4k 1.4×	907 1.2×	73	8.3k
Eirini P. Papapetrou United States	28	5.4k 1.0×	1.0k 0.6×	922 0.8×	690 0.7×	935 1.3×	62	6.4k
Masayo Takahashi Japan	52	10.5k 1.9×	3.5k 2.2×	861 0.8×	918 0.9×	1.6k 2.2×	217	12.5k
Malin Parmar Sweden	48	6.0k 1.1×	3.6k 2.3×	1.0k 0.9×	2.0k 2.0×	494 0.7×	123	8.1k
Haruhisa Inoue Japan	42	4.4k 0.8×	2.0k 1.2×	851 0.8×	508 0.5×	506 0.7×	189	8.5k
In-Hyun Park United States	26	7.0k 1.3×	941 0.6×	1.0k 1.0×	380 0.4×	838 1.2×	32	8.1k
Su‐Chun Zhang United States	38	5.4k 1.0×	2.4k 1.5×	944 0.9×	1.9k 1.8×	492 0.7×	69	6.8k

Countries citing papers authored by Mark Tomishima

Since Specialization

Citations

This map shows the geographic impact of Mark Tomishima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Tomishima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Tomishima more than expected).

Fields of papers citing papers by Mark Tomishima

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Tomishima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Tomishima. The network helps show where Mark Tomishima may publish in the future.

Co-authorship network of co-authors of Mark Tomishima

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Tomishima. A scholar is included among the top collaborators of Mark Tomishima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Tomishima. Mark Tomishima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Solé, Anna, Sandrine Grossetête, Loélia Babin, et al.. (2021). Unraveling Ewing Sarcoma Tumorigenesis Originating from Patient-Derived Mesenchymal Stem Cells. Cancer Research. 81(19). 4994–5006. 41 indexed citations

Amin, Sadaf, Brandoch D. Cook, Ting Zhou, et al.. (2018). Discovery of a drug candidate for GLIS3-associated diabetes. Nature Communications. 9(1). 2681–2681. 47 indexed citations

Zhou, Ting, Lei Tan, G. Cederquist, et al.. (2017). High-Content Screening in hPSC-Neural Progenitors Identifies Drug Candidates that Inhibit Zika Virus Infection in Fetal-like Organoids and Adult Brain. Cell stem cell. 21(2). 274–283.e5. 199 indexed citations

Zhang, Xin‐Jun, Nicolas Renier, Zhuhao Wu, et al.. (2017). Combined small-molecule inhibition accelerates the derivation of functional cortical neurons from human pluripotent stem cells. Nature Biotechnology. 35(2). 154–163. 162 indexed citations

Irion, Stefan, Susan E. Zabierowski, & Mark Tomishima. (2016). Bringing Neural Cell Therapies to the Clinic: Past and Future Strategies. Molecular Therapy — Methods & Clinical Development. 4. 72–82. 23 indexed citations

Thodima, Venkata J., et al.. (2014). miR-18b and miR-518b Target FOXN1 During Epithelial Lineage Differentiation in Pluripotent Cells. Stem Cells and Development. 23(10). 1149–1156. 11 indexed citations

Tomishima, Mark. (2014). Midbrain dopamine neurons from hESCs. 3 indexed citations

Piganeau, Marion, Anne De Cian, Lionel Guittat, et al.. (2013). Cancer translocations in human cells induced by zinc finger and TALE nucleases. Genome Research. 23(7). 1182–1193. 111 indexed citations

Gerhardt, Jeannine, Mark Tomishima, Nikica Zaninović, et al.. (2013). The DNA Replication Program Is Altered at the FMR1 Locus in Fragile X Embryonic Stem Cells. Molecular Cell. 53(1). 19–31. 84 indexed citations

10.

Joubin, Katherine, et al.. (2012). The Endothelial Cell Line bEnd.3 Maintains Human Pluripotent Stem Cells. Stem Cells and Development. 21(12). 2312–2321. 1 indexed citations

11.

Harel, Sivan, Stuart P. Weisberg, Stuart M. Chambers, et al.. (2012). ZFX Controls the Self-Renewal of Human Embryonic Stem Cells. PLoS ONE. 7(8). e42302–e42302. 39 indexed citations

12.

Chambers, Stuart M., Yvonne Mica, Lorenz Studer, & Mark Tomishima. (2011). Converting Human Pluripotent Stem Cells to Neural Tissue and Neurons to Model Neurodegeneration. Methods in molecular biology. 793. 87–97. 29 indexed citations

13.

Hoya-Arias, Ruben, Mark Tomishima, Fabiana Perna, Francesca Voza, & Stephen D. Nimer. (2011). L3MBTL1 Deficiency Directs the Differentiation of Human Embryonic Stem Cells Toward Trophectoderm. Stem Cells and Development. 20(11). 1889–1900. 10 indexed citations

14.

James, Daylon, Hyung-song Nam, Marco Seandel, et al.. (2010). Expansion and maintenance of human embryonic stem cell–derived endothelial cells by TGFβ inhibition is Id1 dependent. Nature Biotechnology. 28(2). 161–166. 235 indexed citations

15.

Chambers, Stuart M., Christopher A. Fasano, Eirini P. Papapetrou, et al.. (2009). Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nature Biotechnology. 27(3). 275–280. 2597 indexed citations breakdown →

16.

Lee, Gabsang, Eirini P. Papapetrou, Hyesoo Kim, et al.. (2009). Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. Nature. 461(7262). 402–406. 649 indexed citations breakdown →

17.

Tabar, Viviane, Mark Tomishima, Georgia Panagiotakos, et al.. (2008). Therapeutic cloning in individual parkinsonian mice. Nature Medicine. 14(4). 379–381. 80 indexed citations

18.

Placantonakis, Dimitris G., Mark Tomishima, Fabien G. Lafaille, et al.. (2008). BAC Transgenesis in Human Embryonic Stem Cells as a Novel Tool to Define the Human Neural Lineage. Stem Cells. 27(3). 521–532. 59 indexed citations

19.

Enquist, Lynn W., Mark Tomishima, Steven P. Gross, & Gregory A. Smith. (2002). Directional spread of an α-herpesvirus in the nervous system. Veterinary Microbiology. 86(1-2). 5–16. 78 indexed citations

20.

Tomishima, Mark, Gregory A. Smith, & L. W. Enquist. (2001). Sorting and Transport of Alpha Herpesviruses in Axons. Traffic. 2(7). 429–436. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact